Bank Of America Corp Clene Inc. Transaction History

Bank Of America Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$0.31 - $0.44 $9,779 - $13,880	-31,547 Reduced 97.61%	772 $0
Q1 2024 May 15, 2024	BUY	$0.28 - $0.53 $3,058 - $5,789	10,923 Added 51.05%	32,319 $13,000
Q4 2023 Feb 14, 2024	SELL	$0.26 - $0.55 $164 - $347	-631 Reduced 2.86%	21,396 $6,000
Q2 2023 Aug 14, 2023	BUY	$0.78 - $1.22 $15,989 - $25,008	20,499 Added 1341.56%	22,027 $19,000
Q1 2023 May 12, 2023	SELL	$0.95 - $1.62 $5,082 - $8,667	-5,350 Reduced 77.78%	1,528 $1,000
Q4 2022 Feb 10, 2023	BUY	$0.92 - $40.2 $27 - $1,206	30 Added 0.44%	6,878 $6,000
Q3 2022 Nov 14, 2022	BUY	$0.33 - $73.0 $249 - $55,261	757 Added 12.43%	6,848 $19,000
Q2 2022 Aug 12, 2022	SELL	$2.1 - $4.12 $120,090 - $235,606	-57,186 Reduced 90.37%	6,091 $15,000
Q1 2022 May 16, 2022	BUY	$2.42 - $4.42 $52,431 - $95,763	21,666 Added 52.07%	63,277 $249,000
Q4 2021 Feb 08, 2022	BUY	$3.95 - $7.53 $120,076 - $228,904	30,399 Added 271.13%	41,611 $170,000
Q3 2021 Nov 15, 2021	BUY	$6.83 - $13.58 $36,560 - $72,693	5,353 Added 91.36%	11,212 $77,000
Q2 2021 Sep 13, 2021	BUY	$6.98 - $13.33 $40,895 - $78,100	5,859 New	5,859 $66,000

230K

25K

Ticker CLNN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 63,502,000
Market Cap $262M
Description
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.